I note the comments about Halcion changing the game. STI only has to offer stability as pathology businesses are being stretched at moment. Chance for STI to call the shots on that company. Maybe Board did and Halcion cameback wanting.
Thank goodness that GTS deal is gone. We do all the hardwork and GTS cleans up. Methinks the Board are starting to realise that all their hardwork will pay off.
" Pharmacy plant currently tendering on 15 contracts, to be announced straight after Agm, sounds great." MD to make ann preceding the AGM although anyone in the contract business will tell you only rely on 1 job in 10.
Disappointing but I think the Board is starting to realise that STI could have a brighter future.
STI Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held